SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-242618
Filing Date
2021-08-11
Accepted
2021-08-11 07:12:03
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 d172637ds3.htm S-3 477502
2 EX-1.2 d172637dex12.htm EX-1.2 203858
3 EX-4.3 d172637dex43.htm EX-4.3 345438
4 EX-4.4 d172637dex44.htm EX-4.4 342711
5 EX-4.5 d172637dex45.htm EX-4.5 34776
6 EX-4.6 d172637dex46.htm EX-4.6 34760
7 EX-5.1 d172637dex51.htm EX-5.1 37341
8 EX-23.1 d172637dex231.htm EX-23.1 2080
9 GRAPHIC g172637g01a01.jpg GRAPHIC 46859
10 GRAPHIC g172637g34h10.jpg GRAPHIC 2110
  Complete submission text file 0001193125-21-242618.txt   1543018
Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Filer) CIK: 0001693011 (see all company filings)

IRS No.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-258702 | Film No.: 211161954
SIC: 2834 Pharmaceutical Preparations